BioRestorative Therapies ... (BRTX)
NASDAQ: BRTX
· Real-Time Price · USD
1.73
-0.11 (-6.23%)
At close: May 13, 2025, 3:59 PM
1.77
2.02%
After-hours: May 13, 2025, 06:47 PM EDT
-6.23% (1D)
| Bid | 1.35 |
| Market Cap | 13M |
| Revenue (ttm) | 401K |
| Net Income (ttm) | -8.98M |
| EPS (ttm) | -1.16 |
| PE Ratio (ttm) | -1.49 |
| Forward PE | -2.22 |
| Analyst | Strong Buy |
| Ask | 2.18 |
| Volume | 162,495 |
| Avg. Volume (20D) | 364,927 |
| Open | 1.88 |
| Previous Close | 1.84 |
| Day's Range | 1.66 - 1.88 |
| 52-Week Range | 1.03 - 2.55 |
| Beta | 0.36 |
About BRTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BRTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BRTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioRestorative Therapies Inc. is scheduled to release its earnings on May 14, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
11 months ago
+20%
BioRestorative Therapies shares are trading higher...
Unlock content with
Pro Subscription
11 months ago
+44.44%
BioRestorative Therapies shares are trading higher after the company announced that it engaged in advanced discussions for a ThermoStem license with a regenerative medicine firm.
1 month ago · seekingalpha.com
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call TranscriptBioRestorative Therapies, Inc. (NASDAQ:BRTX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Lance Alstodt – Chairman and Chief Exe...